Page 3 - Kenvue Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kenvue inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kenvue Inc Today - Breaking & Trending Today

Kenvue Inc. (NYSE:KVUE) Shares Acquired by Isthmus Partners LLC

Isthmus Partners LLC lifted its stake in shares of Kenvue Inc. (NYSE:KVUE – Free Report) by 3.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 522,169 shares of the company’s stock after acquiring an additional 18,432 shares during the quarter. Isthmus Partners LLC’s […] ....

Sanfordc Bernstein , Isthmus Partners , Jpmorgan Chase Co , Goldman Sachs Group , Kenvue Inc , Exchange Commission , Beaumont Financial Advisors , Pinnacle Bancorp Inc , Royal Bank , Skin Health , Dfpg Investments , Royal Capital Wealth Management , Mutual Advisors , Free Report , Financial Advisors , Capital Wealth Management , Stock Down , Get Free Report , Self Care , Visit Holdingschannel , Kenvue Daily ,

Citigroup Reaffirms Neutral Rating for Kenvue (NYSE:KVUE)

Kenvue (NYSE:KVUE – Get Free Report)‘s stock had its “neutral” rating reissued by investment analysts at Citigroup in a research report issued on Tuesday, Marketbeat Ratings reports. They currently have a $21.00 price objective on the stock. Citigroup’s target price would indicate a potential upside of 11.35% from the company’s previous close. Other equities analysts […] ....

United States , Sanfordc Bernstein , Advisor Group , Kenvue Company Profile , Royal Bank , Goldman Sachs Group , Jpmorgan Chase Co , Lincoln National Corp , Victory Capital Management Inc , Securities Inc , Kenvue Inc , Skin Health , Get Free Report , Marketbeat Ratings , National Corp , Capital Management , Retirement Systems , Self Care , Kenvue Daily ,

J&J Acquires Experimental Eczema Drug in $1.25 Billion Cash Deal

J&J Acquires Experimental Eczema Drug in $1.25 Billion Cash Deal
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

Bloomberg Johnson , Kenvue Inc , Numab Therapeutics , Switzerland Based Numab ,

Orion Portfolio Solutions LLC Sells 66,388 Shares of Kenvue Inc. (NYSE:KVUE)

Orion Portfolio Solutions LLC lessened its holdings in shares of Kenvue Inc. (NYSE:KVUE – Free Report) by 26.5% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 183,799 shares of the company’s stock after selling 66,388 shares during the quarter. Orion Portfolio Solutions LLC’s holdings […] ....

William Blair , Mutual Advisors , Jpmorgan Chase Co , Kenvue Inc , Beaumont Financial Advisors , Royal Bank , Royal Capital Wealth Management , Goldman Sachs Group , Dfpg Investments , Orion Portfolio Solutions , Skin Health , Securities Exchange Commission , Pinnacle Bancorp Inc , Free Report , Portfolio Solutions , Financial Advisors , Capital Wealth Management , Trading Down , Get Free Report , Self Care , Kenvue Daily ,

J&J Acquires Experimental Eczema Drug in $1.25B Cash Deal

The therapy, known as NM26, targets two proteins that cause the itchiness and inflammation of eczema. ....

Kenvue Inc , Numab Therapeutics ,